601 - 650 of 8801 Results
Title
Year
-
RESTRICTEDTitle: Emerging hiPSC Models for Drug Discovery in Neurodegenerative DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 15Start Page: 8196End Page: 8196Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22158196Best OA location URL: https://www.mdpi.com/1422-0067/22/15/8196/pdf?version=1627640850Citation Count: 11
-
RESTRICTEDTitle: Neurons and Glia Interplay in α-SynucleinopathiesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 9Start Page: 4994End Page: 4994Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22094994Best OA location URL: https://www.mdpi.com/1422-0067/22/9/4994/pdf?version=1620472084Citation Count: 31
-
RESTRICTEDTitle: Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological DisordersJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 9Start Page: 4536End Page: 4536Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22094536Best OA location URL: https://www.mdpi.com/1422-0067/22/9/4536/pdfCitation Count: 11
-
RESTRICTEDTitle: Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 14Start Page: 4966End Page: 4966Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21144966Best OA location URL: https://www.mdpi.com/1422-0067/21/14/4966/pdf?version=1594721931Citation Count: 23
-
RESTRICTEDTitle: Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting ProceedingsJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0476-1Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-019-0476-1Citation Count: 9
-
RESTRICTEDTitle: Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and ShadowsJournal Name: CellsPublisher: MDPI AGVol: 8Issue #: 11Start Page: 1317End Page: 1317Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells8111317Best OA location URL: https://www.mdpi.com/2073-4409/8/11/1317/pdf?version=1571996609Citation Count: 23
-
RESTRICTEDTitle: Protein misfolding in neurodegenerative diseases: implications and strategiesJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-017-0077-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-017-0077-5Citation Count: 428
-
RESTRICTEDTitle: Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass SpectrometryJournal Name: Molecular & Cellular ProteomicsPublisher: Elsevier BVVol: 22Issue #: 8Start Page: 100608End Page: 100608Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mcpro.2023.100608Best OA location URL: http://www.mcponline.org/article/S1535947623001196/pdfCitation Count: 8
-
RESTRICTEDTitle: PAKs in the brain: Function and dysfunctionJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1864Issue #: 2Start Page: 444End Page: 453Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbadis.2017.11.005Best OA location URL: https://doi.org/10.1016/j.bbadis.2017.11.005Citation Count: 40
-
RESTRICTEDTitle: Review: Somatic mutations in neurodegenerationJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 44Issue #: 3Start Page: 267End Page: 285Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/nan.12465Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nan.12465Citation Count: 73
-
RESTRICTEDTitle: Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluidJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 1179End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41596-022-00787-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561622Citation Count: 35
-
RESTRICTEDTitle: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current optionsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 352Issue #:Start Page: 142End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014Citation Count: 20
-
RESTRICTEDTitle: Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseasesJournal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1237End Page: 1245Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2016.1182990Best OA location URL: https://europepmc.org/articles/pmc5315368?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of actionJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 21Issue #: 5Start Page: 802End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013Citation Count: 246
-
RESTRICTEDTitle: Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluidJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 59Issue #:Start Page: 21End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.016Citation Count: 16
- Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?2023RESTRICTEDTitle: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdfCitation Count: 5
-
RESTRICTEDTitle: Small Molecules to Improve ER Proteostasis in DiseaseJournal Name: Trends in Pharmacological SciencesPublisher: Elsevier BVVol: 40Issue #: 9Start Page: 684End Page: 695Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.tips.2019.07.003Best OA location URL: http://manuscript.elsevier.com/S0165614719301403/pdf/S0165614719301403.pdfCitation Count: 63
-
RESTRICTEDTitle: Clinical neurophysiology of Parkinson’s disease and parkinsonismJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 7Issue #:Start Page: 201End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002Citation Count: 33
-
RESTRICTEDTitle: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’sJournal Name:Publisher:Vol:Issue #:Start Page: 22End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1Citation Count: 1
-
RESTRICTEDTitle: Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”Journal Name: ACS Applied Materials & InterfacesPublisher: American Chemical Society (ACS)Vol: 15Issue #: 10Start Page: 13824End Page: 13824Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acsami.3c02300Best OA location URL: https://doi.org/10.1021/acsami.3c02300Citation Count: 0
-
RESTRICTEDTitle: Novel therapeutic approaches to target neurodegenerationJournal Name: British Journal of PharmacologyPublisher: WileyVol: 180Issue #: 13Start Page: 1651End Page: 1673Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bph.16078Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16078Citation Count: 7
-
RESTRICTEDTitle: Huntington disease: A quarter century of progress since the gene discoveryJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 396Issue #:Start Page: 52End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.09.022Citation Count: 59
-
RESTRICTEDTitle: REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.7916/d84b2zdfCitation Count: 4
-
RESTRICTEDTitle: Juvenile parkinsonism: Differential diagnosis, genetics, and treatmentJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 74End Page: 89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.025Citation Count: 67
-
RESTRICTEDTitle: Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeuticsJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 39End Page: 52Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00702-011-0682-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-011-0682-x.pdfCitation Count: 68
-
RESTRICTEDTitle: Digital technologies: Innovations that transform the face of drug developmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 16Issue #: 8Start Page: 1323End Page: 1330Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.13533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13533Citation Count: 2
-
RESTRICTEDTitle: Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an UpdateJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 5Start Page: 973End Page: 986Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00440Citation Count: 34
-
RESTRICTEDTitle: Unmet needs in Parkinson disease: Motor and non-motorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S7End Page: S12Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802020307380/pdfCitation Count: 60
-
RESTRICTEDTitle: Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17879/freeneuropathology-2021-3326Citation Count: 7
-
RESTRICTEDTitle: γ‐Synuclein and the progression of cancerJournal Name: The FASEB JournalPublisher: WileyVol: 21Issue #: 13Start Page: 3419End Page: 3430Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.07-8379revCitation Count: 91
-
RESTRICTEDTitle: Clinical and Imaging Markers of Prodromal Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00395Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00395/pdfCitation Count: 91
-
RESTRICTEDTitle: Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 36Issue #:Start Page: 20End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.02.003Citation Count: 33
-
RESTRICTEDTitle: Harnessing ionic mechanisms to achieve disease modification in neurodegenerative disordersJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 147Issue #:Start Page: 104343End Page: 104343Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2019.104343Best OA location URL: https://flore.unifi.it/bitstream/2158/1175329/1/2019%20Harnessing%20ion%20channel.pdfCitation Count: 7
-
RESTRICTEDTitle: Striatal cholinergic interneurons and Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 47Issue #: 10Start Page: 1148End Page: 1158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13638Best OA location URL: https://europepmc.org/articles/pmc6074051?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: Blood-based biomarkers for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #:Start Page: S99End Page: S103Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1353-8020(13)70025-7Best OA location URL: https://europepmc.org/articles/pmc4070332?pdf=renderCitation Count: 123
-
RESTRICTEDTitle: Biomarkers in Parkinson's disease: Advances and strategiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S106End Page: S110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.048Best OA location URL: https://europepmc.org/articles/pmc5120398?pdf=renderCitation Count: 133
-
RESTRICTEDTitle: Oxidized DJ-1 as a possible biomarker of Parkinson’s diseaseJournal Name: Journal of Clinical Biochemistry and NutritionPublisher: The Society for Free Radical Research JapanVol: 54Issue #: 3Start Page: 138End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3164/jcbn.13-108Best OA location URL: https://www.jstage.jst.go.jp/article/jcbn/54/3/54_13-108/_pdfCitation Count: 61
-
RESTRICTEDTitle: Leucine‐rich repeat kinase 2 and Parkinson's diseaseJournal Name: PROTEOMICSPublisher: WileyVol: 17Issue #: 1-2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pmic.201600092Citation Count: 23
-
RESTRICTEDTitle: Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synucleinJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 42Issue #: 1Start Page: 51End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/nan.12299Citation Count: 66
-
RESTRICTEDTitle: Intersection of immunometabolism and immunosenescence during agingJournal Name: Current Opinion in PharmacologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 107End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coph.2021.01.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481958Citation Count: 21
-
RESTRICTEDTitle: Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive ImpairmentJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 5Start Page: 455End Page: 463Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-011-0212-0Best OA location URL: https://europepmc.org/articles/pmc3213691?pdf=renderCitation Count: 10
-
RESTRICTEDTitle: Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory ScienceJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 4Issue #: Suppl. 1Start Page: 28End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000512500Best OA location URL: https://www.karger.com/Article/Pdf/512500Citation Count: 43
-
RESTRICTEDTitle: Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010–2016: A Systematic Literature ReviewJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 2Issue #: 1Start Page: 11End Page: 30Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1159/000486347Best OA location URL: https://www.karger.com/Article/Pdf/486347Citation Count: 69
-
RESTRICTEDTitle: Personalized Care in Late-Stage Parkinson’s Disease: Challenges and OpportunitiesJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 5Start Page: 813End Page: 813Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12050813Best OA location URL: https://www.mdpi.com/2075-4426/12/5/813/pdf?version=1652864161Citation Count: 4
-
RESTRICTEDTitle: Parkinson’s Disease and Sugar Intake—Reasons for and Consequences of a Still Unclear CravingJournal Name: NutrientsPublisher: MDPI AGVol: 14Issue #: 15Start Page: 3240End Page: 3240Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/nu14153240Best OA location URL: https://www.mdpi.com/2072-6643/14/15/3240/pdf?version=1659947851Citation Count: 12
-
RESTRICTEDTitle: Diagnosis and Management of Functional Tic-Like PhenomenaJournal Name: Journal of Clinical MedicinePublisher: MDPI AGVol: 11Issue #: 21Start Page: 6470End Page: 6470Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/jcm11216470Best OA location URL: https://www.mdpi.com/2077-0383/11/21/6470/pdf?version=1667888847Citation Count: 17
-
RESTRICTEDTitle: Alpha-Synuclein PET Tracer Development—An Overview about Current EffortsJournal Name: PharmaceuticalsPublisher: MDPI AGVol: 14Issue #: 9Start Page: 847End Page: 847Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ph14090847Best OA location URL: https://www.mdpi.com/1424-8247/14/9/847/pdf?version=1632368283Citation Count: 57
-
RESTRICTEDTitle: Moving towards Integrated and Personalized Care in Parkinson’s Disease: A Framework Proposal for Training Parkinson NursesJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 11Issue #: 7Start Page: 623End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm11070623Best OA location URL: https://www.mdpi.com/2075-4426/11/7/623/pdf?version=1625207859Citation Count: 20
-
RESTRICTEDTitle: Modulation of Neuroinflammation by the Gut Microbiota in Prion and Prion-Like DiseasesJournal Name: PathogensPublisher: MDPI AGVol: 10Issue #: 7Start Page: 887End Page: 887Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/pathogens10070887Best OA location URL: https://www.mdpi.com/2076-0817/10/7/887/pdf?version=1626165753Citation Count: 7
-
RESTRICTEDTitle: Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s DiseaseJournal Name: MoleculesPublisher: MDPI AGVol: 25Issue #: 3Start Page: 453End Page: 453Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules25030453Best OA location URL: https://www.mdpi.com/1420-3049/25/3/453/pdf?version=1580039503Citation Count: 47